title: Clinical significance of serum levels of immune-associated molecules, uric acid and soluble MHC class I chain-related molecules A and B, as diagnostic tumor markers for pancreatic ductal adenocarcinoma.
abstract: Immune-associated molecules play important roles in cancer development and progression. The aims of this study were to determine the diagnostic utility of uric acid (UA) and soluble MHC class I chain-related molecules A (sMICA) and B (sMICB) in pancreatic ductal adenocarcinoma (PDAC) compared with those of cancer antigen 19-9 (CA19-9), the most commonly available tumor marker for PDAC. We evaluated serum levels of UA, sMICA and sMICB along the carcinogenic process of PDAC obtained from 148 individuals composed of normal (n = 70), chronic pancreatitis (n = 23) and PDAC (n = 55), and compared them with those of CA19-9. We also evaluated the correlations of these biomarkers with tumor size, resectability or TNM stage, and tested logistic regression to ascertain the potential usability of these markers for the detection of PDAC. We also investigated the correlations among these biomarkers. Serum UA, sMICA and sMICB differed significantly according to groups (Kruskal-Wallis, P < 0.05), and were closely correlated with the development of PDAC. Serum sMICA were correlated with distant metastasis and sMICB were correlated with unresectability. Sensitivity and specificity of sMICA and sMICB were higher than CA19-9, and a multi-maker panel using all tested markers (UA, sMICA, sMICB and CA19-9) demonstrated the best potential for detecting PDAC (94.2% sensitivity at 93.3% specificity). The three tested markers also showed added diagnostic potentials to overcome the limitation of CA19-9 by differentiation of PDAC from non-cancerous conditions when CA19-9 is inappropriate. In conclusion, serum UA, sMICA and sMICB might be useful screening or differential diagnostic biomarkers for PDAC to complement CA19-9.
authors: Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
authors: Hye Won
authors: HW
authors: Chung
authors: Jong-Baeck
authors: JB
authors: Lim
references: Tumori. 2001 Sep-Oct;87(5):337-9
references: 11765186
references: J Clin Oncol. 2006 Nov 20;24(33):5313-27
references: 17060676
references: Int J Cancer. 2006 Feb 1;118(3):684-7
references: 16094621
references: Cytokine Growth Factor Rev. 2008 Feb;19(1):79-92
references: 18155952
references: Nature. 2002 Oct 17;419(6908):734-8
references: 12384702
references: Nature. 2003 Oct 2;425(6957):516-21
references: 14520412
references: Cancer Res. 1988 May 15;48(10):2916-8
references: 3359448
references: Biometrics. 2002 Sep;58(3):657-64
references: 12230001
references: Science. 1999 Jul 30;285(5428):727-9
references: 10426993
references: J Immunol. 2002 Oct 15;169(8):4098-102
references: 12370336
references: J Urol. 2007 Oct;178(4 Pt 1):1238-43; discussion 1243-4
references: 17698111
references: Ann Oncol. 2007 Nov;18(11):1893-7
references: 17785768
references: Mol Cancer. 2011 Feb 10;10(1):13
references: 21310022
references: Cancer Immunol Immunother. 2006 Dec;55(12):1584-9
references: 16636811
references: Hum Immunol. 2006 Mar;67(3):188-95
references: 16698441
references: Cleve Clin J Med. 2006 Dec;73(12):1059-64
references: 17190309
references: Gastroenterol Hepatol. 1999 Aug-Sep;22(7):335-41
references: 10535205
references: Cell Host Microbe. 2009 Apr 23;5(4):376-85
references: 19380116
references: Annu Rev Immunol. 2004;22:929-79
references: 15032600
references: JOP. 2005 Nov 10;6(6):552-61
references: 16286705
references: Nat Immunol. 2008 Sep;9(9):1013-5
references: 18711442
references: CA Cancer J Clin. 2000 Jul-Aug;50(4):241-68
references: 10986966
references: Diabetes Care. 2008 Feb;31(2):361-2
references: 17977935
references: Proc Natl Acad Sci U S A. 1981 Nov;78(11):6858-62
references: 6947260
references: Med Hypotheses. 1989 Mar;28(3):193-5
references: 2710024
references: J Natl Compr Canc Netw. 2005 Sep;3(5):637-42
references: 16194455
references: Cancer. 1962 Jan-Feb;15:122-9
references: 13923731
references: Int J Biol Markers. 2004 Jul-Sep;19(3):196-202
references: 15503821
references: J Immunol. 2004 Jun 1;172(11):6519-23
references: 15153463
references: Hepatogastroenterology. 2006 Jan-Feb;53(67):1-4
references: 16506366
references: Int J Cancer. 2006 Nov 15;119(10):2359-65
references: 16929491